BioCentury
ARTICLE | Distillery Therapeutics

A mAb blocking IL-1 co-receptor for inflammatory, autoimmune diseases

September 12, 2019 9:33 PM UTC

INDICATION: Inflammation; allergy; psoriasis...

BCIQ Company Profiles

University of Colorado Denver